Literature DB >> 2180857

[Erythema migrans arciforme et palpabile (T-cell pseudolymphoma)].

I Lohrisch1, E Alexandrakis, H Maywurm, J Petres.   

Abstract

A 65-year-old man with recurrent erythema migrans arciforme et palpabile (EMAP) is reported. EMAP is characterized as a T-cell pseudolymphoma, the cell populations of which are composed of T-helper- and T-suppressor cells in a ratio of 2:1. EMAP can therefore not be differentiated immunohistologically from the lymphocytic infiltration of Jessner-Kanof.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180857

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  [Annular erythematous plaques].

Authors:  C Dullweber; A Körber; J Dissemond
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

2.  [Palpable arciforme migratory erythema].

Authors:  G Wagner; S Bartsch; C Rose; M M Sachse
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

3.  Possibly drug-induced palpable migratory arciform erythema.

Authors:  Fernando Luiz Teixeira Dantas; Neusa Yuriko Sakai Valente; Isis Suga Veronez; Priscila Kakizaki; Juliana Ribeiro Leitão; Rafael Cavanellas Fraga
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.